SCHW
64
2
ZBH
60
-2
TGNA
53
2
EL
20
3
AZO
46
-3
C
58
-2
ACN
47
-2
VRSK
73
5
HRB
51
2
EXR
57
-2
CVX
46
5
LLY
39
9
CSX
51
-2
COP
56
2
XEL
67
2
ORLY
53
-3
VLO
40
-2
AIG
38
-4
CINF
47
2
CAG
30
4
SCHW
64
2
ZBH
60
-2
TGNA
53
2
EL
20
3
AZO
46
-3
C
58
-2
ACN
47
-2
VRSK
73
5
HRB
51
2
EXR
57
-2
CVX
46
5
LLY
39
9
CSX
51
-2
COP
56
2
XEL
67
2
ORLY
53
-3
VLO
40
-2
AIG
38
-4
CINF
47
2
CAG
30
4
Financhill
Back

IDEAYA Biosciences 10K Form

Sell
46

IDYA
IDEAYA Biosciences

Last Price:
25.78
Seasonality Move:
18.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IDYA News And Ratings

See the #1 stock for the next 7 days that we like better than IDYA

IDYA Financial Statistics

Sales & Book Value

Annual Sales: $23.39M
Cash Flow: $-49.69M
Price / Cash Flow: 0
Annual Sales: $13.67
Price / Book: 1.92

Profitability

EPS (TTM): -2.33000
Net Income (TTM): $-179.61M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

IDEAYA Biosciences Earnings Forecast

Key IDEAYA Biosciences Financial Ratios

  • The Research & Development expenses have been 553.81% of Revenue.
  • The Net Earning history of IDYA is -483.05% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

IDEAYA Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IDYA
CUSIP: 45166A
Website: ideayabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IDYA Technical Analysis vs Fundamental Analysis

Sell
46
IDEAYA Biosciences (IDYA) is a Sell

Is IDEAYA Biosciences a Buy or a Sell?